In a society that often treats those living with a disability as "less than," columnist Mary Shaniqua reminds her community ...

Stay updated on Beam Therapeutics Inc.'s latest advancements in Sickle Cell Disease and alpha-1 antitrypsin deficiency treatments. Click for my BEAM stock update.

Novo Nordisk’s Wegovy helped heart disease patients end up in the hospital less often than those who didn’t receive the ...

A team from MY Hospital has screened more than 400 tribal students residing in hostels across Indore. These students hail ...

Briana Pringle, 22, of Little Rock, is pretty busy these days, and that’s a good thing. The Helena-West Helena native studies ...

Jigawa State Government has raised concern over the increasing cases of kidney disease in the state. State commissioner for ...

For all of its challenges, living with sickle cell has offered columnist Oluwatosin Adesoye resilience, empathy, support, and happiness.

Beam Therapeutics' early clinical data shows promising results for sickle cell disease treatment using CRISPR gene editing tool. One patient died ...

Beam Therapeutics (BEAM) stock gains as Leerink upgrades the biotech despite a fatality in a gene editing study, citing an ...

Because the eyes can potentially reveal signals about conditions like diabetes, heart disease, kidney disease, sickle cell ...

The mother of a teenager with sickle cell disease said medical treatment for the genetic blood disorder was a "postcode ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...